key: cord-0741080-bbmmvku2
authors: Perivolaropoulos, Christos; Vlacha, Vasiliki
title: A reduction of the number of assays and turnaround time by optimizing polymerase chain reaction (PCR) pooled testing for SARS‐CoV‐2
date: 2021-04-06
journal: J Med Virol
DOI: 10.1002/jmv.26972
sha: b36a93daff5d0c3697854ba74f6370484f9c9233
doc_id: 741080
cord_uid: bbmmvku2

Early detection of the severe acute respiratory syndrome coronavirus 2 infection can decrease the spread of the disease and provide therapeutic options promptly in affected individuals. However, the diagnosis by reverse‐transcription polymerase chain reaction is costly and time‐consuming. Several methods of group testing have been developed to overcome this problem. The proposed strategy offers optimization of group testing according to the available resources by decreasing not only the number of the assays but also the turnaround time. The initial classification of the samples would be done according to the intention of testing defined as diagnostic or screening/surveillance, achieving the best possible homogeneity. The proposed stratification of pooling is based on branching (divisions) and depth (levels of re‐pooling) of the original group in association with the estimated probability of a positive sample. The dilutional effect of the grouped samples has also been considered. The margins of minimum and maximum conservation of assays of pooled specimens are calculated and the optimum strategy can be selected in association with the probability of positive samples in the original group. This algorithm intends to be a useful tool for group testing offering a choice of strategies according to the requirements.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly expanded around the globe. The confirmed fatality ratio of coronavirus disease 2019 (COVID-19) is ranging from 0.1% to 25% in different countries. 1 Even in the era of COVID-19 vaccines, the early identification and isolation of affected individuals is one of the most important factors for the protection of vulnerable people and the reduction of the disease spread. An analysis comparing the mortality rate and the testing performed in several countries has shown a negative correlation between those two parameters. 2 Since the start of the outbreak, a variety of testing assays have been developed, 3 , 4 such as reverse-transcription polymerase chain reaction (RT-PCR) for SARS-COV-2, antigen testing, and serology testing. 5 However, RT-PCR remains the gold standard in detection of SARS-CoV-2. 6 Numerous RT-PCR assays have been designed aiming to maximize the sensitivity and specificity as well as to shorten the turnaround time and to maximize the number of assessed samples. To be able to handle a high volume of specimens in a limited time, high throughput systems have been developed. 7 However, testing for SARS-CoV-2 could be a challenge 8 as it requires a significant number of resources regarding testing facilities, personnel, and testing availability. The cost of testing is a significant constraining factor. Several countries have experienced a shortage of testing capacity. Performing individual testing is time-consuming and it also requires a huge number of resources. For this reason, assays examining samples in groups have been developed, to tackle this issue. The first pooling sample method was developed in 1943 by Dorfan, who used pooled blood samples to test an antigen for syphilis. 9 This technique has been applied for diagnoses of several infectious agents such as malaria, HIV, hepatitis B, and hepatitis C, [10] [11] [12] since then. Various methods have been recommended regarding the grouping of the samples, taking into consideration different factors such as the available resources and the turnaround time of the assay. 13 Additionally, important factors concerning the efficacy of the assays such as the sensitivity, the specificity, the limit of detection, 14 A significant step of the process of pooling assays is to determine the stratification of grouping of the initial samples. In this study, we introduce a method of RT-PCR testing for SARS-Cov-2 by sample pooling, and we suggest a flexible multi-way process of re-pooling based on the probability of SARS-CoV-2 positivity. We subsequently report the maximum and minimum benefits of each stratified method. The optimum process can be selected based on the available resources and the needs. The final goal is to reduce the cost and the turnaround time.

An algorithm was constructed for the optimization of testing groups of samples for SARS-CoV-2 infection (Figure 1 ). The algorithm is based on the separation of the specimens in groups whose number depends on the expected ratio of positive samples. The probability of positive samples in the original group will be estimated according to the intention of testing, which may be characterized as either diagnostic or screening/surveillance.

To construct our algorithm, we make the following fundamental assumption about the nature of a COVID test; one can achieve arbitrarily high sensitivity for a diluted sample by repeatedly performing the test on the same sample. This is true, for example, if the sensitivity of different tests on the same sample represents independent stochastic variables.

Before analyzing the final proposed algorithm, we describe an auxiliary algorithm, similar to the one known in computer science as "binary are the PUC. We test one of them in replicates. If the result is positive, we deduce that the positive sample exists in the pool we have just tested, otherwise, it exists in the other 2 k − 1 pool. Following the same procedure, the size of the pools we test decreases until we reach a pool containing only one sample which must be the positive sample. We perform k + 1 steps in total by this method. Assuming that k is small enough that one replicate offers acceptable efficiency for a 2 k pool (as explained in the discussion, k < 5 for our purposes, 2 4 = 16 samples), we perform one test per step. In a group with more than 16 samples, additional tests are performed in replicates to increase the sensitivity. Therefore, via this method, we can find one positive sample in a population of size N performing log 2 (N) + 1 tests. For example, from a population of 2 5 = 32 samples, we can find one positive sample by performing only six tests.

In each step of the proposed algorithm, we test the entire PUC.

Each new PUC consists of the sub-pools of all the positive pools in the previous PUC. The negative pools and sub-pools are excluded.

Finally, each constructed pool in the auxiliary algorithm is a 2 i pool (where i is a natural number) and has exactly 2 sub-pools. In the proposed algorithm, we generalize this approach by constructing each pool from b sub-pools. As a result, all pools contain b i samples. For an instance of the algorithm where the largest pool is of size b k the parameters b and k are called "branching" and "depth," respectively. Based on these parameters the samples are separated into groups of size b k and the algorithm is then applied to each group. such that s = 4 2 . Assuming that the positivity is 1%, both methods offer a minimum reduction of assays by 86% compared to individual testing as shown in Table 1 . However, the difference in depth affects the turnaround time of the assay. and 48%, respectively (Table 1) . However, when the positivity rate is 20%, this type of grouping results in only 4% minimum and 28% maximum of gained assays ( Table 1 ). The same stratification seems to be optimum for 5% positivity. To demonstrate our method more clearly, we illustrate an example in Figure 4 .

Groups shown in red represent positive samples.

In the case of 1% prevalence, two different strategies When the values of the minimum gained assays approach those of the maximum gained assays, then the number of required tests is more predictable. However, this is mostly true in the case of a low positivity rate. As the prevalence of the disease increases, the discrepancy in the values between the maximum and minimum gained assays increases as well. Higher values of branching also increase this discrepancy but in some cases, they offer a more beneficial outcome.

Higher values of depth augment only the minimum reduction of the assays (the best possible scenario). These findings are shown in Table 1 . It is well known that false-negative results can set off a cascade of consequences by inhibiting the isolation of an infected person.

One of the major factors affecting the test sensitivity is the dilutional effect of the pooled samples. To mitigate the dilutional effect, we perform the assays in replicates in the case of group size above 16 (2 4 ) before we declare the pooled samples as negative. This decision is based on the report by Kim et al. 23 19 selected pool sizes between 5 and 50 by comparing a high-throughput approach with a contextsensitivity method. It has been suggested that the viral load is another important factor affecting the sensitivity of the assay in pooled samples. It has been shown that in each two-fold dilution, the cycle PERIVOLAROPOULOS AND VLACHA threshold (C t ) value increased by 1.24. 24 This was possible either when pooling before or after the RNA extraction. Specimens with low viral load (C t > 35) showed 13.3% false-negative results. 26 Another study with pooling size 9-10 has reported a loss of 2.87C t for E gene, 3.36C t for RdRP gene, and 2.99C t for N gene. 27 Pools consisting of many samples may require additional amplification cycles due to lower viral load in the pooled samples.

Although RT-PCR and pooling techniques, which are discussed in this study, are widely used for diagnostic and screening purposes, they impose limitations that should be taken into consideration. RT-PCR testing requires equipment, trained personnel, and reagents which are costly. 28 Regarding the pooling technique, the FDA has reported shortcomings such as the dilution of the pool sample, the variability of results depending on the prevalence of the disease in the community, and difficulty in the collection of adequate specimens. 29 A further limitation of our method is the requirement of pre-assay epidemiological evaluation to classify the specimens as diagnostic or as screening/surveillance. In addition, during the proposed process each sample is evaluated several times. Although this has the beneficial effect of improving the sensitivity of the method, it also increases the risk of intralab errors during labeling and augments the possibility of lab contamination.

In conclusion, this algorithm is intended to be a useful tool for laboratory use according to the available resources and the final targeted benefit. Our method gives the flexibility to organize the turnaround time, the personnel involved, and finally the cost.

Estimation of COVID-19 prevalence in Italy

COVID-19 mortality is negatively associated with test number and government effectiveness

COVID-19 clinical diagnostics and testing technology

Report from the American Society for Microbiology COVID-19 International Summit

Serum IgA, IgM, and IgG responses in COVID-19

Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19

Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system

Challenges and controversies to testing for COVID-19. Kraft CS

The detection of defective members of large populations

High-throughput pooling and real-time PCR-based strategy for malaria detection

Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries

Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development

Pooled-testing procedures for screening high volume clinical specimens in heterogeneous populations

SARS-CoV2 testing: the limit of detection matters

An evaluation of laboratory efficiency in Shanghai emergency by turn around times level

Laboratory turnaround time

Pooled Sample Testing and Screening Testing for COVID-19. FDA

Assessment of specimen pooling to conserve SARS CoV-2 testing resources

Simulation of pooled-sample analysis strategies for COVID-19 mass testing

Group testing against COVID-19

Pooling of coronavirus tests under unknown prevalence

Pooling upper respiratory specimens for rapid mass screening of COVID-19 by real-time RT-PCR

Evaluation of COVID-19 RT-qPCR test in multi sample pools

Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection

Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19

Sample pooling for SARS-CoV-2 RT-PCR screening

Novel coronavirus disease (COVID-19): paving the road for rapid detection and point-of-care diagnostics

tests-duringpublic-health-emergency-revised How to cite this article: Perivolaropoulos C, Vlacha V. A reduction of the number of assays and turnaround time by optimizing polymerase chain reaction (PCR) pooled testing for SARS-CoV-2

The authors declare that there are no conflict of interests.

Christos Perivolaropoulos and VasilikiVlacha contributed equally to the conception, design, analysis, interpretation, drafting, writing of the manuscript and the final approval of the version submitted

The peer review history for this article is available at https://publons. com/publon/10.1002/jmv.26972

The data that support the findings of this study are available from the corresponding author upon reasonable request.

http://orcid.org/0000-0003-1845-6025